Jaguar Health (JAGX) Revenue (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Revenue data on file, last reported at $20.3 million in Q1 2026.

• On a quarterly basis, Revenue rose 815.63% year-over-year to $20.3 million in Q1 2026; TTM through Mar 2026 was $29.6 million, a 155.96% increase from a year earlier, with the FY2025 full-year figure at $11.5 million, down 1.52% from the prior year.
• Revenue for Q1 2026 stood at $20.3 million, up from $3.2 million in the prior quarter.
• Over the last five years, Revenue for JAGX reached as high as $20.3 million in Q1 2026 and fell as low as $20000.0 in Q1 2022.
• Historically, Revenue has averaged $3.4 million across 5 years, with a median of $2.8 million in 2023.
• Across the five-year window, Revenue sank 98.46% in 2022 and jumped 7087.5% in 2023, its largest moves.
• Year by year, Revenue stood at $32000.0 in 2022, then soared by 7087.5% to $2.3 million in 2023, then jumped by 52.57% to $3.5 million in 2024, then decreased by 7.81% to $3.2 million in 2025, then soared by 526.65% to $20.3 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $20.3 million in Q1 2026, $3.2 million in Q4 2025, and $3.1 million in Q3 2025.